Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for ...
Ottawa, Precedence Research, April 16, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the worldwide generic drugs market size was valued at USD 445.62 billion in 2024 and is projected to ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. President Trump announced new tariffs on generic drugs, effective August 1, 2026, starting ...
Ohio's six-month freeze on new Medicaid home care and hospice providers is set to expire Nov. 14, raising concerns among disabled residents who face gaps when aides leave. South Dakota voters will ...
In an era of escalating healthcare costs, Americans increasingly face crucial decisions about their prescription medications. The choice between generic and brand-name drugs represents a significant ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options ...
Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...
Drugmakers agreed to pay $475 million over generic drug price-fixing allegations. See if your past prescriptions qualify before 9.
The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries. Oral PrEP ...
Emory is the data editor at STAT. He’s a data journalist with a background in bioinformatics and molecular biology. You can reach Emory on Signal at jaspar.01. Elaine’s stories explore the boom in new ...
On October 21, 2026, the U.S. Food & Drug Administration (“FDA”) published final guidance titled “Regulatory Considerations for Prescription ...